Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowAugust 23, 2024 — 9:15 AM - 9:45 AM ET
Nasdaq MarketSite, 4 Times Square, New York
Actuate Therapeutics (Nasdaq: ACTU), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).
In honor of the occasion, Daniel Schmitt, President & Chief Executive Officer, rings the Opening Bell.
